X0609 4 2026-06-29 0001806952 Lyell Immunopharma, Inc. LYEL 0002095697 Innovative Cellular Therapeutics Holdings Ltd true 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9008 CAYMAN ISLANDS true false Common Stock 2026-06-29 4 J 0 76000 0 D 2857500 D Represents shares of Common Stock transferred by the Reporting Person to Wuxiong, Inc. as broker commission in connection with the Upfront Payment (as such term is defined in the License Agreement, dated November 6, 2025, between the Issuer and the Reporting Person). The transaction was a transfer of securities for no cash consideration to the Reporting Person and is reported under transaction code J. Reflects 2,933,500 shares of Common Stock beneficially owned by the Reporting Person immediately prior to the reported transaction, less the 76,000 shares transferred. Innovative Cellular Therapeutics Holdings Limited By: /s/ Lei Xiao Name: Lei Xiao Title: Chief Executive Officer 2026-07-01